RE: questions for CC1. When will the result of the test for effectiveness of Econiche against the other newly banned E. coli strains be made public?
2. Is BNC currently doing anything to find a U.S. partnership for Econiche?
3. What plan does BNC has to promote the share price?
4. Why were some of the development in research mentioned in McGrae's letter not published in the PR?
5. Why does the ASX get more info and news published than here?
6. What vaccines currently imported from the U.S. and their projected $ volume can be manufactured by BNC in the new vaccine plant? Is there any plan currently to produce and market them while waiting for Econiche to commercialize?